nrti การใช้

• There are several more NRTIs in development.
• This was the NRTI called zidovudine.
• In the late 1980s, during further development of NRTIs, the field of NNRTIs discovery began.
• Elvucitabine belongs to a class ( group ) of HIV drugs called nucleoside reverse transcriptase inhibitors ( NRTIs ).
• It was born as the Natural Resources Training Institute ( NRTI ) in 1992 under the Ministry of Agriculture.
• The authors found that there is no meaningful difference between abacavir-containing regimens and other NRTI-containing regimens.
• By blocking reverse transcriptase, NRTIs prevent HIV from multiplying and can reduce the amount of HIV in the body.
• "' Stampidine "'is an experimental nucleoside reverse transcriptase inhibitor ( NRTI ) with anti-HIV activity.
• Unfortunately, NRTIs / NtRTIs compete as substrates for not only viral but also host DNA synthesis, acting as drug toxicity / side effects.
• NRTIs ( nucleoside reverse transcriptase inhibitors ) or drugs such as AZT, ddI, ddC that prevent the virus from replicating are recommended for children.
• Some nucleoside analogues, however, can function both as NRTIs and polymerase inhibitors for other viruses ( e . g ., hepatitis B ).
• NRTIs block an HIV enzyme called reverse transcriptase . ( An enzyme is a protein that starts or increases the speed of a chemical reaction ).
• Some of the NRTIs that are in development exhibit various attractive pharmacological properties that could make them desirable for the treatment of patients in need of new agents.
• The NRTI joined the Royal University of Bhutan ( RUB ) in 2003 as a founding member college, and was named thereafter as the College of Natural Resources.
• "' Elvucitabine "'is an experimental nucleoside reverse transcriptase inhibitor ( NRTI ), developed by Achillion Pharmaceuticals, Inc . for the treatment of HIV infection.
• As NRTI, the institute awarded Diploma courses in the field of Agriculture, Animal Husbandry, and Forestry for the mid-level extension workers of the Ministry of Agriculture.
• NNRTIs are not incorporated into the viral DNA like NRTIs, but instead inhibit the movement of protein domains of reverse transcriptase that are needed to carry out the process of DNA synthesis.
• Nucleoside reverse-transcriptase inhibitors ( NRTIs ) and efavirenz have different binding targets, so cross-resistance is unlikely; the same is true with regard to efavirenz and protease inhibitors.
• A systematic review assessed the effects and safety of abacavir-containing regimens as first-line therapy for children between 1 month and 18 years of age when compared to regimens with other NRTIs.
• Using combinations of NRTIs was in practice prior to the second FDA approval and the triple drug combinations with dual NRTIs and a protease inhibitor ( PI ) were not far off by this time.